Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index
In children with persistent asthma, inhaled glucocorticoids decrease symptoms and exacerbations, decrease the need for rescue bronchodilator medications, improve airway patency and reduce airway hyperresponsiveness. When administered in the lowest doses that prevent symptoms and eliminate the need f...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/1999/957127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553981695492096 |
|---|---|
| author | F Estelle R Simons |
| author_facet | F Estelle R Simons |
| author_sort | F Estelle R Simons |
| collection | DOAJ |
| description | In children with persistent asthma, inhaled glucocorticoids decrease symptoms and exacerbations, decrease the need for rescue bronchodilator medications, improve airway patency and reduce airway hyperresponsiveness. When administered in the lowest doses that prevent symptoms and eliminate the need for supplemental courses of oral glucocorticoids, they are unlikely to cause clinically important systemic adverse events. Inhaled glucocorticoids have a favourable risk to benefit ratio in this population. |
| format | Article |
| id | doaj-art-eb1807a7fa684b4a854d8ce3e806ea06 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 1999-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-eb1807a7fa684b4a854d8ce3e806ea062025-02-03T05:52:50ZengWileyCanadian Respiratory Journal1198-22411999-01-016217517810.1155/1999/957127Inhaled Glucocoriticoids in Children: A Facourable Therapeutic IndexF Estelle R Simons0Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, CanadaIn children with persistent asthma, inhaled glucocorticoids decrease symptoms and exacerbations, decrease the need for rescue bronchodilator medications, improve airway patency and reduce airway hyperresponsiveness. When administered in the lowest doses that prevent symptoms and eliminate the need for supplemental courses of oral glucocorticoids, they are unlikely to cause clinically important systemic adverse events. Inhaled glucocorticoids have a favourable risk to benefit ratio in this population.http://dx.doi.org/10.1155/1999/957127 |
| spellingShingle | F Estelle R Simons Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index Canadian Respiratory Journal |
| title | Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index |
| title_full | Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index |
| title_fullStr | Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index |
| title_full_unstemmed | Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index |
| title_short | Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index |
| title_sort | inhaled glucocoriticoids in children a facourable therapeutic index |
| url | http://dx.doi.org/10.1155/1999/957127 |
| work_keys_str_mv | AT festellersimons inhaledglucocoriticoidsinchildrenafacourabletherapeuticindex |